Maco Pharma
USPTO PatentsView assignee record - 12 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).
The verdict
According to USPTO PatentsView, Maco ranks #22,932 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 13 technology areas.
- #22,932
- of 49,997 US assignees by volume
- 47th percentile
- by Innovation Score (34.1/100)
- 13.4
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R22932 · Foreign Corporation #22,932 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #22,932/49,997
- PHOTO-FINISH Mac & Mac Hydrodemol…
- CPC-FOCUS A61L · 13 areas
- INNOV-THIN 34.1/100
- CLAIMS-RICH 13.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mac & Mac Hydrodemolition Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Maco’s 34.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Maco
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Maco Pharma · this assignee 34
Maco Pharma · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Maco's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Maco?
Each dot is one of Maco’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maco’s own 13.4 claims/patent is ABOVE the 10.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Maco's grants concentrate
Maco Pharma is a focused PatentsView assignee: 13 CPC subclasses with 50% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2017. By volume, Maco sits between Mycomagic Biotechnology Co., Ltd. and Mallinckrodt Pharma IP Trading D.A.C..
Maco's three-year grant acceleration
Maco Pharma shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Maco's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mycomagic Biotech…
Mycomagic Biotechnology Co., Ltd.
12 patents
- Myeloid Therapeut…
Myeloid Therapeutics, Inc.
12 patents
- Mac & Mac Hydrode…
Mac & Mac Hydrodemolition Inc.
12 patents
- Machinesense
MachineSense, LLC
12 patents
- Magna Mirrors Hol…
Magna Mirrors Holding GmbH
12 patents
- Magneco/Metrel
Magneco/Metrel, Inc.
12 patents
- Mainetti
Mainetti GmbH
12 patents
- Mallinckrodt Phar…
Mallinckrodt Pharma IP Trading D.A.C.
12 patents
- Maco Pharma ◀
Maco Pharma
12 patents
What this shows Maco holds 12 patents at rank #22,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Maco
By rank, the assignees closest to #22,974 in granted patent volume.
- Mycomagic Biotechnology Co., Ltd. #22,970 · 12 patents
- Myeloid Therapeutics, Inc. #22,971 · 12 patents
- Mac & Mac Hydrodemolition Inc. #22,972 · 12 patents
- MachineSense, LLC #22,973 · 12 patents
- Magna Mirrors Holding GmbH #22,975 · 12 patents
- Magneco/Metrel, Inc. #22,976 · 12 patents
- Mainetti GmbH #22,977 · 12 patents
- Mallinckrodt Pharma IP Trading D.A.C. #22,978 · 12 patents
Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)
Other assignees with the most granted patents in Maco's primary technology class.
- The Procter & Gamble Company 378 in class
- Ethicon, Inc. 277 in class
- Abbott Cardiovascular Systems, Inc. 252 in class
- Boston Scientific Scimed, Inc. 240 in class
- Covidien LP 174 in class
- Warsaw Orthopedic, Inc. 167 in class
- DePuy Synthes Products, Inc. 161 in class
- W.L. Gore & Associates GmbH 146 in class
Maco's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 47th percentile higher than 47% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 25.0% |
| 2017 | 1 | 8.3% |
| 2019 | 2 | 16.7% |
| 2021 | 1 | 8.3% |
| 2023 | 1 | 8.3% |
| 2024 | 1 | 8.3% |
| 2025partial year | 3 | 25.0% |
Which technologies does Maco Pharma patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Maco Pharma's patent record in context - here's where to go next.
- Maco Pharma's lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 50% of its portfolio - see every assignee active in that class. Explore A61L
- Ranked #22,932 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Maco Pharma against Mycomagic Biotechnology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.